drugset / Trial / NCT00821496

Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects

NCT00821496

Phase 1 Completed 20 enrolled VIVUS LLC
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is desgigned to look at the effect of multiple dosing administration of VI-0521 on Oral Contraceptive medication.

Timeline

Start
2009-01
Primary completion
2009-03
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Norethindrone Unknown Oral
Subject VI-0521 Unknown Oral
Subject ethinyl estradiol Small molecule Oral

Indications

No indication recorded.